PPH (VanEck Pharmaceutical ETF) Stock Analysis - SEC Filings

VanEck Pharmaceutical ETF (PPH) is a publicly traded the market company. As of May 21, 2026, PPH trades at $102.63 with a market cap of $0 and a P/E ratio of 0.00. PPH moved +0.16% today. Year to date, PPH is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces PPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find PPH SEC filings?

Rallies organizes PPH SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

PPH Key Metrics

Key financial metrics for PPH
MetricValue
Price$102.63
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume125.21K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest PPH News

PPH Analyst Consensus

PPH analyst coverage data. Average price target: $0.00.

Common questions about PPH

Where can I find PPH SEC filings?
Rallies organizes PPH SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show PPH 10-K and 10-Q filings?
Rallies organizes PPH SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is PPH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PPH. It does not provide personalized investment advice.
PPH

PPH